Clinical Trial Update: Empagliflozin and Dapagliflozin in Patients Hospitalized for Acute Decompensated Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 trial update on empagliflozin and dapagliflozin in patients hospitalized for acute decompensated heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Empagliflozin (empagliflozin)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Acute Decompensated Heart Failure | Phase 3 | Status: UNKNOWN